Theophylline

Oral
Intravenous
Class
Bronchodilators
Subclass
Nonselective phosphodiesterase inhibitors
Substance name
Theophylline, 1, 3-dimethylxanthine
Brand names
Elixophyllin®, Uniphyl®
Common formulations
Elixir, Oral solution, Tablet
See also
Theophylline ER (Theo-24®)
Dosage and administration
Adults patients
Symptomatic relief
Reversible airway obstruction in patients with asthma
Loading: 5 mg/kg PO × 1 in a patient who has not received any theophylline in the previous 24 hours
Subsequently: 300 mg PO daily, in 3-4 divided doses, for 3 days
Maintenance: 400-600 mg PO daily, in 3-4 divided doses
Taken with meals.
Reversible airway obstruction in patients with COPD
Loading: 5 mg/kg PO × 1 in a patient who has not received any theophylline in the previous 24 hours
Subsequently: 300 mg PO daily, in 3-4 divided doses, for 3 days
Maintenance: 400-600 mg PO daily, in 3-4 divided doses
Taken with meals.
Treatment
Bradycardia in patients with SND
200-400 mg PO daily, in divided doses
Bradycardia in patients with spinal cord injuryOff-label
5-10 mg/kg PO daily, in divided doses, titrated to effect
Bradycardia, after heart transplantationOff-label
Loading: 300 mg IV once
Subsequently: 5-10 mg/kg PO daily, in divided doses, titrated to a therapeutic serum level of 10-20 mcg/mL
Central sleep apnea in patients with HFOff-label
200-300 mg PO daily, in 3-4 divided doses
Central sleep apnea in patients with high-altitude periodic breathingOff-label
250 mg PO BID
Indications for use
Labeled indications
Adults
Symptomatic relief of reversible airway obstruction in patients with asthma
Symptomatic relief of reversible airway obstruction in patients with COPD
Treatment of bradycardia in patients with SND
Off-label indications
Adults
Treatment of bradycardia in patients with spinal cord injury
Treatment of bradycardia, after heart transplantation
Treatment of central sleep apnea in patients with HF
Treatment of central sleep apnea in patients with high-altitude periodic breathing
Safety risks
Contraindications
Hypersensitivity to theophylline or its components
Warnings and precautions
Exacerbation of cardiac arrhythmias
Use extreme caution in patients with cardiac arrhythmias (not including bradyarrhythmias).
Exacerbation of peptic ulcer disease
Use extreme caution in patients with active peptic ulcer disease.
Increased theophylline levels
Use caution in patients with acute pulmonary edema, congestive HF, cor pulmonale, high and/or prolonged fever, hypothyroidism, liver disease, renal impairment, sepsis with multi-organ failure, shock, or cessation of smoking, as well as in the elderly.
Seizure
Use extreme caution in patients with seizure disorders.
Specific populations
Renal impairment
eGFR ≥ 15 mL/min/1.73 m²
Use acceptable. No dose adjustment required.
eGFR < 15 mL/min/1.73 m²
Use with caution. Monitor serum concentrations.
Renal replacement therapy
Continuous renal replacement
Use acceptable. No dose adjustment required.
Intermittent hemodialysis
Use with caution. Administer the dose after dialysis session.
Peritoneal dialysis
Use with caution.
Hepatic impairment
Any severity
Use with caution. Reduce dose. Monitor serum concentrations.
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: A
Generally acceptable for use. Evidence of fetal harm in animals. The 2020 ERS/TSANZ task force statement suggests that theophylline is compatible with pregnancy.
Breastfeeding
Acceptable for use during breastfeeding.
The 2020 ERS/TSANZ task force statement suggests that theophylline is compatible with breastfeeding.
Low excretion in breastmilk (5-25%).
Unknown drug levels in breastfed infants.
May potentially cause adverse effects in breastfed infants.
Adverse reactions
Unknown frequency
Peptic ulcer disease, intracranial hemorrhage, tachycardia, ↑ urine free cortisol, ↑ blood glucose, ↑ serum total cholesterol, ↓ serum free T3, ↑ serum uric acid, diarrhea, nausea, vomiting, dizziness, headache, insomnia, seizure, tremor, stuttering, irritability, restlessness, fever
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource